Lumos Pharma
(NASDAQ) LUMO
Lumos Pharma Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$2.21M
Net Income (TTM)
$34.92M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
LUMO News
LUMO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Lumos Pharma
Industry
Biotechnology
Sector
Health CareEmployees
33
CEO
Richard J. Hawkins
Website
www.lumos-pharma.comHeadquarters
Austin, TX 78756, US
LUMO Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-18%
Net Income Margin
-17%
Return on Equity
-78%
Return on Capital
-1%
Return on Assets
-84%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$2.05M
Operating Income
$36.61M
EBITDA
$36.57M
Operating Cash Flow
$31.09M
Capital Expenditure
$0.00
Free Cash Flow
$31.09M
Cash & ST Invst.
$36.08M
Total Debt
$585.00K
Lumos Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$726.00K
+10271.4%
Gross Profit
$726.00K
+72700.0%
Gross Margin
100.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
30
N/A
Net Income
$7.47M
+10.0%
EBITDA
$7.64M
+14.4%
Quarterly Fundamentals
Net Cash
$13.35M
-68.5%
Accounts Receivable
$174.00K
+1.2%
Inventory
$0.00
N/A
Long Term Debt
$42.00K
-70.6%
Short Term Debt
$130.00K
-48.4%
Return on Assets
-83.75%
N/A
Return on Invested Capital
-1.09%
N/A
Free Cash Flow
$5.01M
-247.6%
Operating Cash Flow
$5.01M
+36.0%